Trevi Therapeutics, Inc. — Director's Dealing 2021

Aug 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Trevi Therapeutics, Inc. (TRVI)
CIK: 0001563880
Period of Report: 2021-08-09

Reporting Person: Delfini Lisa (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-09	Stock Option (right to buy)	$1.97	A	100000	Acquired	2031-08-08	Common Stock (100000)	Direct

Footnotes

F1: This option was granted on August 9, 2021. The 100,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on August 9, 2022 and as to the remaining 75% of the shares in equal monthly installments thereafter, through August 9, 2025.